CAR-NK Cells: From Natural Basis to Design for Kill
Chimeric antigen receptors (CARs) are fusion proteins with an extracellular antigen recognition domain and numerous intracellular signaling domains that have been genetically modified. CAR-engineered T lymphocyte-based therapies have shown great success against blood cancers; however, potential fata...
Main Authors: | Muhammad Babar Khawar, Haibo Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.707542/full |
Similar Items
-
From barriers to novel strategies: smarter CAR T therapy hits hard to tumors
by: Muhammad Babar Khawar, et al.
Published: (2023-07-01) -
Neoantigens and NK Cells: “Trick or Treat” the Cancers?
by: Dan Lv, et al.
Published: (2022-07-01) -
Nano-immunoengineering of CAR-T cell therapy against tumor microenvironment: The way forward in combating cancer
by: Muhammad Babar Khawar, et al.
Published: (2023-03-01) -
Current Progress of CAR-NK Therapy in Cancer Treatment
by: Zhaojun Pang, et al.
Published: (2022-09-01) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
by: Sergey Kulemzin, et al.
Published: (2021-11-01)